moderna

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule... Wikipedia

Formerly called: ModeRNA Therapeutics (2010–2018)
Type: Public
Traded as: NASDAQ: MRNA, S&P 500 component
ISIN: [ ISIN: [ US60770K1079]]
Industry: Biotechnology
Founders: Derrick Rossi, Timothy A. Springer, Robert S. Langer, Kenneth R. Chien, Noubar Afeyan
Key people: Stéphane Bancel (CEO), Noubar Afeyan (chairman), Stephen Hoge (president), Jamey Mock (CFO)
Products: Spikevax, Vaccine candidates
Revenue: US$1.9 billion (2025)
Operating income: US$-2.8 billion (2025)
Total assets: US$14.1 billion (2024)
Total equity: US$10.9 billion (2024)
Owners: Stéphane Bancel (7.3%), Noubar Afeyan (5.0%), Robert S. Langer (4.0%), Stephen Hoge (1.3%)
Number of employees: 5,800(2024)
Website: modernatx.com
Data source: DuckDuckGo